Wellington Shields & Co., LLC Abbott Laboratories Transaction History

Wellington Shields & Co., LLC

$321 Million
Q3 2024

A detailed history of Wellington Shields & Co., LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 26,736 shares of ABT stock, worth $3.12 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

26,736

Previous 27,118 1.41%

Holding current value

$3.12 Million

Previous $2.82 Million 8.2%

% of portfolio

0.95%

Previous 0.93%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $38,226 - $45,125	-382 Reduced 1.41%	26,736 $3.05 Million
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $23,369 - $26,086	-232 Reduced 0.85%	27,118 $2.82 Million
Q1 2024 May 23, 2024	BUY	$109.52 - $120.96 $12,813 - $14,152	117 Added 0.43%	27,350 $3.11 Million
Q1 2024 May 23, 2024	SELL	$109.52 - $120.96 $12,813 - $14,152	-117 Reduced 0.43%	27,233 $3.1 Million
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $12,813 - $14,152	117 Added 0.43%	27,350 $3.11 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $106,604 - $130,492	-1,182 Reduced 4.16%	27,233 $3 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $434,470 - $521,291	4,548 Added 19.06%	28,415 $2.75 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $498,760 - $555,723	-4,949 Reduced 17.17%	23,867 $2.6 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $93,373 - $109,905	-964 Reduced 3.24%	28,816 $2.92 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $169,016 - $198,282	1,778 Added 6.35%	29,780 $3.27 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $44,993 - $52,093	-465 Reduced 1.63%	28,002 $2.71 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $5,307 - $6,415	-52 Reduced 0.18%	28,467 $3.09 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $231,574 - $282,390	2,031 Added 7.67%	28,519 $3.38 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $256,361 - $313,899	2,219 Added 9.14%	26,488 $3.73 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $4,666 - $5,162	40 Added 0.17%	24,269 $2.87 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $13,858 - $16,313	131 Added 0.54%	24,229 $2.81 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $51,263 - $60,396	-471 Reduced 1.92%	24,098 $2.89 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $2,730 - $2,974	26 Added 0.11%	24,569 $2.69 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $20,985 - $25,485	229 Added 0.94%	24,543 $2.67 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $56,049 - $71,736	732 Added 3.1%	24,314 $2.22 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $14,574 - $21,311	232 Added 0.99%	23,582 $1.86 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $1.83 Million - $2.04 Million	23,350 New	23,350 $2.03 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $1.91 Million - $2.07 Million	-23,289 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $2,405 - $2,805	33 Added 0.14%	23,289 $1.96 Million
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $2,251 - $2,722	34 Added 0.15%	23,256 $1.86 Million
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $28,321 - $32,084	432 Added 1.9%	23,222 $1.68 Million
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $2,128 - $2,567	35 Added 0.15%	22,790 $1.67 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $15,256 - $16,838	-265 Reduced 1.15%	22,755 $1.39 Million
Q1 2018 May 03, 2018	BUY	$56.27 - $63.62 $2,081 - $2,353	37 Added 0.16%	23,020 $0
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $1,986 - $2,126	37 Added 0.16%	22,983 $1.31 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $1.1 Million - $1.23 Million	22,946	22,946 $0

Others Institutions Holding ABT

# of Institutions

3,198

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.

Account

Wellington Shields & Co., LLC Abbott Laboratories Transaction History